Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man. 1978

A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas

UI MeSH Term Description Entries
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013418 Sulfamethazine A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides. Benzenesulfonamide, 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)-,Sulfadimidine,Sulphamethazine,Sulfadimezine,Sulphamezathine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
June 1981, The Journal of pharmacy and pharmacology,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
August 1990, Clinical pharmacology and therapeutics,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
April 1980, The New Zealand medical journal,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
January 1974, Current therapeutic research, clinical and experimental,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
January 1975, Modern problems of pharmacopsychiatry,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
January 1985, Archives internationales de pharmacodynamie et de therapie,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
June 2005, Clinical nutrition (Edinburgh, Scotland),
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
July 1982, The Journal of the Association of Physicians of India,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
March 2010, The Journal of investigative dermatology,
A Gulaid, and I M James, and C M Kaye, and O R Lewellen, and E Roberts, and M Sankey, and J Smith, and R Templeton, and R J Thomas
August 1982, Clinical nephrology,
Copied contents to your clipboard!